Evidence mapPaperPMID 29747423Full record

ReviewInternational journal of environmental research and public health2018

Use of Diabetes Treatment Satisfaction Questionnaire in Diabetes Care: Importance of Patient-Reported Outcomes.

Yoshifumi Saisho

4 registry-linked trialsOpen access · goldAbstract readReview
In one paragraph

Review in International journal of environmental research and public health, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 79 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed, 2 pooled it
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07284511 phase2 / phase3recruitingstarted 2026, after this paper: background citation

Fully Closed-Loop Glucose Control in Adults With Type 1 Diabetes Using Tirzepatide: a Randomized, Multi-center, Open-label, Non-inferiority, Parallel Trial

Ran2026Enrolled105Registered outcomes35Posted comparisons0ConditionsT1D, T1DM, T1DM - Type 1 Diabetes Mellitus, Type 1 DiabetesArmsCarbohydrate Counting, No Meal Announcement, Tandem Control-IQ Automated Insulin Delivery System (with Dexcom G7 CGM), Tirzepatide
Open the trial in the graph
NCT04542148 phase2active not recruitingnot on this mapstarted 2022, after this paper: background citation

Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes (Close the GAP)

TypeinterventionalSponsorUniversity of Alabama at BirminghamRan2022 to 2026Enrolled120ConditionsDiabetes Mellitus, Type 2, Preterm Birth, Pregnancy, High Risk, Diabetes, GestationalArmsSliding Scale Insulin, Up-Titration of Home Insulin, Continuous Insulin Infusion, Dexcom G6 Professional Continuous Glucose Monitor
NCT04783441 narecruitingnot on this mapstarted 2021, after this paper: background citation

Continuous Glucose Monitoring (CGM) to Improve Glycemic Control in Kidney Transplant Recipients

TypeinterventionalSponsorUniversity of California, DavisRan2021 to 2026Enrolled80ConditionsKidney Transplant, Complications, Diabetes Mellitus, Type 2, Insulin Dependent DiabetesArmsDexcom G6, Dexcom G6 blinded sensor
NCT06624553 phase2completednot on this mapstarted 2022, after this paper: background citation

Effect of Monitoring With Freestyle Libre 2 Glucose Sensor on Treatment Satisfaction in Patients With Type 2 Diabetes Mellitus: Exploratory Study in Patients Starting Monitoring

TypeinterventionalSponsorFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauRan2022 to 2023Enrolled50ConditionsDiabetes Mellitus, Type 2ArmsFreeStyle Libre 2, flash glucose monitoring
3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 2 syntheses or guidelines pooled it, 139 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Yoshifumi SaishoDepartment of Internal Medicine, Keio University School of Medicine, 1608582 Tokyo, Japan. ysaisho@z5.keio.jp.ORCID 0000-0002-6071-4393
Keio University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The efficacy of diabetes treatment should not be evaluated solely by HbA1c levels as they should also focus on patient-reported outcomes (PROs), such as patient satisfaction, wellbeing and quality of life. The Diabetes Treatment Satisfaction Questionnaire (DTSQ) has been developed to assess patient satisfaction with diabetes treatment. DTSQ has been translated into more than 100 languages and is widely used in many countries, since it is relatively easy to answer and is used for both patients with and without medical therapy. Novel therapeutic options, such as insulin analogs, incretin-based therapy and sodium-glucose cotransporter 2 (SGLT2) inhibitors, have been shown to improve patient satisfaction using DTSQ for assessments. DTSQ is not only used for comparisons between different medications or treatment strategies, but also can be used to assess the quality of diabetes care in clinical settings. This is important as an improvement in treatment satisfaction may enhance patients' self-efficacy and adherence to therapy, leading to the achievement of long-term stable glycemic control and reduced risk of diabetic complications. In this review, we summarize the current topics in DTSQ, introducing our own experience, and discuss the role of PROs in diabetes treatment.

Indexed as

Patient Reported Outcome MeasuresPatient SatisfactionDiabetes Mellitus, Type 2Humansceiling effectpatient-reported outcomequality of lifetreatment satisfaction

Identifiers

PMID29747423
PMCPMC5981986
OpenAlexW2801605705

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.